Synribo Approve for Chronic Myelogenous Leukemia

Published November 1, 2012

Synribo Approve for Chronic Myelogenous Leukemia

Filed under: drug treatment programs washington dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease. An estimated 5,430 … Synribo is approved under …
Read more on Kansas City infoZine

Pharmacy-made pregnancy drug under scrutiny after meningitis outbreak

Filed under: drug treatment programs washington dc

Neither the federal agency that oversees state Medicaid programs, the state Medicaid directors association, the drug manufacturer or doctors' groups could say how many state programs restrict access to the FDA-approved drug. Backlash Over Makena's …
Read more on NBCNews.com (blog)

Boehringer Ingelheim to Pay Million to Resolve False Claims Act Allegations

Filed under: drug treatment programs washington dc

Washington, DC – Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $ 95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD …
Read more on Yumanewsnow